NFKB1 and primary effusion lymphoma: As well as Kaposi’s sarcoma, KSHV induces primary effusion lymphoma cells, in which NFκB is constitutively activated by vFLIP directly binding to an inhibitor of NFκB (IκB) kinase (IKK) [54,55].